Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing

Journal of Clinical Pathology
Georgina L RylandPiers Blombery

Abstract

Multiple myeloma is a genomically complex haematological malignancy with many genomic alterations recognised as important in diagnosis, prognosis and therapeutic decision making. Here, we provide a summary of genomic findings identified through routine diagnostic next-generation sequencing at our centre. A cohort of 86 patients with multiple myeloma underwent diagnostic sequencing using a custom hybridisation-based panel targeting 104 genes. Sequence variants, genome-wide copy number changes and structural rearrangements were detected using an inhouse-developed bioinformatics pipeline. At least one mutation was found in 69 (80%) patients. Frequently mutated genes included TP53 (36%), KRAS (22.1%), NRAS (15.1%), FAM46C/DIS3 (8.1%) and TET2/FGFR3 (5.8%), including multiple mutations not previously described in myeloma. Importantly we observed TP53 mutations in the absence of a 17 p deletion in 8% of the cohort, highlighting the need for sequencing-based assessment in addition to cytogenetics to identify these high-risk patients. Multiple novel copy number changes and immunoglobulin heavy chain translocations are also discussed. Our results demonstrate that many clinically relevant genomic findings remain in multiple myeloma which...Continue Reading

References

Aug 10, 2005·The Journal of Biological Chemistry·Kristina ElwardPhilippe Gasque
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jan 12, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Seon Young KimUNKNOWN Korea Multiple Myeloma Working Party
Mar 25, 2011·Nature·Michael A ChapmanTodd R Golub
Oct 10, 2012·British Journal of Haematology·Rocío Ramos-MedinaGiovanna Roncador
Aug 21, 2013·Nature Genetics·Daniel ChubbHartmut Goldschmidt
Jan 17, 2014·Nature Communications·Niccolo BolliNikhil C Munshi
Apr 15, 2014·Cell Reports·Benoit MiottoPierre-Antoine Defossez
Apr 7, 2015·Blood Reviews·K M KortümA K Stewart
Apr 26, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jarle BruunRagnhild A Lothe
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian A WalkerGareth J Morgan
Nov 15, 2016·The Journal of Clinical Investigation·Daniel W SherbenouBin Liu
Dec 3, 2017·Nature Communications·A CleynenH Avet-Loiseau

❮ Previous
Next ❯

Citations

Apr 23, 2020·Leukemia & Lymphoma·Ella R ThompsonPiers Blombery
Aug 9, 2020·Journal of Clinical Pathology·Kohei FujikuraYukihiro Imai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease & TET2

Cardiovascular diseases are the number one cause of deaths globally. Tet methylcytosine dioxygenase 2 (TET2)-mediated hematopoiesis has been implicated in accelerating heart failure. Here is the latest research on cardiovascular diseases and TET2.